A detailed history of Citigroup Inc transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Citigroup Inc holds 18,849 shares of MEDP stock, worth $6.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,849
Previous 22,035 14.46%
Holding current value
$6.57 Million
Previous $9.08 Million 30.74%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$320.58 - $457.29 $1.02 Million - $1.46 Million
-3,186 Reduced 14.46%
18,849 $6.29 Million
Q2 2024

Aug 12, 2024

BUY
$372.0 - $424.34 $1.74 Million - $1.98 Million
4,669 Added 26.89%
22,035 $9.08 Million
Q1 2024

May 10, 2024

BUY
$284.87 - $413.31 $1.74 Million - $2.53 Million
6,123 Added 54.46%
17,366 $7.02 Million
Q4 2023

Feb 09, 2024

BUY
$227.52 - $312.68 $845,691 - $1.16 Million
3,717 Added 49.39%
11,243 $3.45 Million
Q3 2023

Nov 09, 2023

SELL
$233.98 - $281.67 $1.34 Million - $1.61 Million
-5,723 Reduced 43.2%
7,526 $1.82 Million
Q2 2023

Aug 10, 2023

BUY
$187.26 - $240.17 $1.31 Million - $1.68 Million
6,995 Added 111.85%
13,249 $3.18 Million
Q1 2023

May 11, 2023

BUY
$174.31 - $239.52 $79,485 - $109,221
456 Added 7.86%
6,254 $1.18 Million
Q4 2022

Feb 09, 2023

SELL
$153.06 - $226.57 $376,833 - $557,815
-2,462 Reduced 29.81%
5,798 $1.23 Million
Q3 2022

Nov 10, 2022

BUY
$145.13 - $182.49 $356,439 - $448,195
2,456 Added 42.32%
8,260 $1.3 Million
Q2 2022

Aug 10, 2022

BUY
$130.2 - $168.03 $327,973 - $423,267
2,519 Added 76.68%
5,804 $868,000
Q1 2022

May 12, 2022

SELL
$138.87 - $214.31 $1.06 Million - $1.63 Million
-7,610 Reduced 69.85%
3,285 $537,000
Q4 2021

Feb 10, 2022

SELL
$182.74 - $227.9 $6.65 Million - $8.3 Million
-36,405 Reduced 76.97%
10,895 $2.37 Million
Q3 2021

Nov 10, 2021

BUY
$170.18 - $198.21 $8.05 Million - $9.38 Million
47,300 New
47,300 $8.95 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.